Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luke B Snell

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Cell Reports. Medicine|February 3, 2026
Antibody escape drives emergence of diverse spike haplotypes resembling variants of concern in persistent SARS-CoV-2 infectionsLuke B Snell, Suzanne Pickering, Adela Alcolea-Medina, et al.
Microbial Genomics|August 17, 2023
Feasibility and clinical utility of local rapid Nanopore influenza A virus whole genome sequencing for integrated outbreak management, genotypic resistance detection and timely surveillanceTom G S Williams, Luke B Snell, Christopher Alder, et al.
The Lancet. Microbe|October 4, 2025
Rapid pan-microbial metagenomics for pathogen detection and personalised therapy in the intensive care unit: a single-centre prospective observational studyAdela Alcolea-Medina, Luke B Snell, Gul Humayun, et al.
Open Forum Infectious Diseases|January 25, 2024
A Multinational Case Series Describing Successful Treatment of Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection Caused by Omicron Sublineages With Prolonged Courses of Nirmatrelvir/RitonavirLuke B Snell, Aimee McGreal-Bellone, Clemency Nye, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 16, 2023
The ongoing Streptococcus pyogenes (Group A Streptococcus) outbreak in London, United Kingdom, in December 2022: a molecular epidemiology studyAdela Alcolea-Medina, Luke B Snell, Christopher Alder, et al.
Nature Communications|December 31, 2024
Antibodies to the RBD of SARS-CoV-2 spike mediate productive infection of primary human macrophagesSuzanne Pickering, Harry Wilson, Enrico Bravo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2022
Real-Time Whole Genome Sequencing to Guide Patient-Tailored Therapy of Severe Acute Respiratory Syndrome Coronavirus 2 InfectionLuke B Snell, Adela Alcolea-Medina, Themoula Charalampous, et al.
The Lancet. Microbe|July 6, 2021
Comparative performance of SARS-CoV-2 lateral flow antigen tests and association with detection of infectious virus in clinical specimens: a single-centre laboratory evaluation studySuzanne Pickering, Rahul Batra, Blair Merrick, et al.
BMJ (Clinical Research Ed.)|July 28, 2022
Clinical features and novel presentations of human monkeypox in a central London centre during the 2022 outbreak: descriptive case seriesAatish Patel, Julia Bilinska, Jerry C H Tam, et al.
Genome Medicine|November 17, 2021
Evaluating the potential for respiratory metagenomics to improve treatment of secondary infection and detection of nosocomial transmission on expanded COVID-19 intensive care unitsThemoula Charalampous, Adela Alcolea-Medina, Luke B Snell, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Cell Reports. Medicine|February 3, 2026
Antibody escape drives emergence of diverse spike haplotypes resembling variants of concern in persistent SARS-CoV-2 infectionsLuke B Snell, Suzanne Pickering, Adela Alcolea-Medina, et al.
Microbial Genomics|August 17, 2023
Feasibility and clinical utility of local rapid Nanopore influenza A virus whole genome sequencing for integrated outbreak management, genotypic resistance detection and timely surveillanceTom G S Williams, Luke B Snell, Christopher Alder, et al.
The Lancet. Microbe|October 4, 2025
Rapid pan-microbial metagenomics for pathogen detection and personalised therapy in the intensive care unit: a single-centre prospective observational studyAdela Alcolea-Medina, Luke B Snell, Gul Humayun, et al.
Open Forum Infectious Diseases|January 25, 2024
A Multinational Case Series Describing Successful Treatment of Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection Caused by Omicron Sublineages With Prolonged Courses of Nirmatrelvir/RitonavirLuke B Snell, Aimee McGreal-Bellone, Clemency Nye, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 16, 2023
The ongoing Streptococcus pyogenes (Group A Streptococcus) outbreak in London, United Kingdom, in December 2022: a molecular epidemiology studyAdela Alcolea-Medina, Luke B Snell, Christopher Alder, et al.
Nature Communications|December 31, 2024
Antibodies to the RBD of SARS-CoV-2 spike mediate productive infection of primary human macrophagesSuzanne Pickering, Harry Wilson, Enrico Bravo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2022
Real-Time Whole Genome Sequencing to Guide Patient-Tailored Therapy of Severe Acute Respiratory Syndrome Coronavirus 2 InfectionLuke B Snell, Adela Alcolea-Medina, Themoula Charalampous, et al.
The Lancet. Microbe|July 6, 2021
Comparative performance of SARS-CoV-2 lateral flow antigen tests and association with detection of infectious virus in clinical specimens: a single-centre laboratory evaluation studySuzanne Pickering, Rahul Batra, Blair Merrick, et al.
BMJ (Clinical Research Ed.)|July 28, 2022
Clinical features and novel presentations of human monkeypox in a central London centre during the 2022 outbreak: descriptive case seriesAatish Patel, Julia Bilinska, Jerry C H Tam, et al.
Genome Medicine|November 17, 2021
Evaluating the potential for respiratory metagenomics to improve treatment of secondary infection and detection of nosocomial transmission on expanded COVID-19 intensive care unitsThemoula Charalampous, Adela Alcolea-Medina, Luke B Snell, et al.
Pageof 4